The effect of opting‐in versus opting‐out forming on the rate of reported variants of questionable significance in prenatal microarray
International Journal of Gynecology & Obstetrics · 2024
DOI: 10.1002/ijgo.15805 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Jumana Haddad-Halloun und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Human Genetic Institute, Carmel Medical Center, Haifa, Israel. Hauptthemen laut MEDLINE: Prenatal Diagnosis, Microarray Analysis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Objective
To examine the effect of patient‐selected opt‐in versus opt‐out option on the rate of reported variants of uncertain clinical significance (VOUS) and high‐frequency low‐penetrant (HFLP) findings in prenatal microarray testing.
Methods
A standard microarray consent form in Israel includes a requirement to note patient choice to be or not to be informed about the presence of VOUS and HFLP variants. The original form was designed as an opting‐out method, in which the women had to actively mark if they did not want to be informed about questionable findings. In the authors' Genetic Institute, the form was changed for an opting‐in option in October 2019. In this study we have compared the rates of reported VOUS and HFLP variants between the opt‐in and opt‐out periods.
Results
Of the 1014 prenatal CMA tests, 590 (58.2%) were performed in the opt‐out period. A significant decrease in the rate of women requesting to be informed of VOUS findings was noted (66.8% in opt‐out period vs 34.0% in opt‐in period), yielding a relative risk (RR) of 0.46 (95% confidence interval [CI] 0.39–0.53). Rate of women preferring to be informed of HFLP variants decreased from 75.3% to 48.1% (RR 0.52, 95% CI 0.45–0.60).
Discussion
We present a simple and effective method to decrease the rate of reported findings of questionable significance in the prenatal setting. These results are important not only for microarray results, but also for next‐generation sequencing techniques, such as whole exome or genome sequencing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Human Genetic Institute, Carmel Medical Center, Haifa, Israel.
- The Hebrew University of Jerusalem, Jerusalem, Israel.
- The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
ORCID-Profile: Lena Sagi-Dain
Zitieren
APA
Haddad-Halloun, J., Wexler, A., Echar, M., Harari-Shaham, A., Polager-Modan, S., Zaatry, R., Maayouf, R., Assadi, M., Krivoruk, O., Peleg, A., & Sagi-Dain, L. (2024). The effect of opting‐in versus opting‐out forming on the rate of reported variants of questionable significance in prenatal microarray. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15805
Vancouver
Haddad-Halloun J, Wexler A, Echar M, Harari-Shaham A, Polager-Modan S, Zaatry R, et al. The effect of opting‐in versus opting‐out forming on the rate of reported variants of questionable significance in prenatal microarray. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.15805
BibTeX
@article{HaddadHalloun2024,
author = {Haddad-Halloun, Jumana and Wexler, Ava and Echar, Moran and Harari-Shaham, Amalia and Polager-Modan, Shirley and Zaatry, Rawan and Maayouf, Rasha and Assadi, Maisa and Krivoruk, Olga and Peleg, Amir and Sagi-Dain, Lena},
title = {The effect of opting‐in versus opting‐out forming on the rate of reported variants of questionable significance in prenatal microarray},
journal = {International Journal of Gynecology & Obstetrics},
year = {2024},
doi = {10.1002/ijgo.15805}
}
EUVIMED